Effect | Decrease |
Trial Design | Double blind |
Trial Length | n/a |
Number of Subjects | 51 |
Sex | n/a |
Bone specific ALP was reduced in women taking 20-50mg of Pueraria relative to placebo, suggesting improvements to bone health over time (despite bone mineral density not being measured in this study)